Medpace Holdings Inc (MEDP)
378.69
-3.75
(-0.98%)
USD |
NASDAQ |
Apr 18, 10:01
Medpace Holdings Profit Margin (Quarterly): 15.71% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.71% |
September 30, 2023 | 14.32% |
June 30, 2023 | 13.25% |
March 31, 2023 | 16.79% |
December 31, 2022 | 17.42% |
September 30, 2022 | 17.21% |
June 30, 2022 | 14.05% |
March 31, 2022 | 18.53% |
December 31, 2021 | 16.22% |
September 30, 2021 | 16.43% |
June 30, 2021 | 14.35% |
March 31, 2021 | 16.66% |
December 31, 2020 | 19.59% |
September 30, 2020 | 18.00% |
June 30, 2020 | 11.76% |
March 31, 2020 | 12.54% |
December 31, 2019 | 12.97% |
September 30, 2019 | 11.09% |
June 30, 2019 | 12.82% |
Date | Value |
---|---|
March 31, 2019 | 9.56% |
December 31, 2018 | 11.85% |
September 30, 2018 | 10.77% |
June 30, 2018 | 9.74% |
March 31, 2018 | 8.92% |
December 31, 2017 | 10.02% |
September 30, 2017 | 8.89% |
June 30, 2017 | 8.99% |
March 31, 2017 | 7.92% |
December 31, 2016 | -0.02% |
September 30, 2016 | 4.67% |
June 30, 2016 | 4.68% |
March 31, 2016 | 3.46% |
December 31, 2015 | -8.93% |
September 30, 2015 | -0.14% |
June 30, 2015 | 0.11% |
March 31, 2015 | -0.07% |
March 31, 2014 | -1.59% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
11.09%
Minimum
Sep 2019
19.59%
Maximum
Dec 2020
15.25%
Average
15.71%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
Charles River Laboratories International Inc | 18.46% |
Avid Bioservices Inc | -37.44% |
Iovance Biotherapeutics Inc | -24.15K% |
Renovaro Inc | -- |
Candel Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 65.63% |
Return on Assets | 19.37% |
Return on Invested Capital | 59.55% |
Gross Profit Margin (Quarterly) | 27.45% |
Operating Margin (Quarterly) | 17.52% |
Return on Net Operating Assets | 22.96% |